BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshida H, Shiraishi K, Kato T. Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers. Cancers 2021;13:6351. [DOI: 10.3390/cancers13246351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Evans AM, Salnikov M, Tessier TM, Mymryk JS. Reduced MHC Class I and II Expression in HPV-Negative vs. HPV-Positive Cervical Cancers. Cells 2022;11. [PMID: 36497170 DOI: 10.3390/cells11233911] [Reference Citation Analysis]
2 Giannella L, Di Giuseppe J, Delli Carpini G, Grelloni C, Fichera M, Sartini G, Caimmi S, Natalini L, Ciavattini A. HPV-Negative Adenocarcinomas of the Uterine Cervix: From Molecular Characterization to Clinical Implications. Int J Mol Sci 2022;23. [PMID: 36499345 DOI: 10.3390/ijms232315022] [Reference Citation Analysis]
3 Chen Z, Lin H, Zheng J, Cai L, Chen Z, Li J, Yu L. Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection. BMC Infect Dis 2022;22:893. [DOI: 10.1186/s12879-022-07893-3] [Reference Citation Analysis]
4 Evans AM, Salnikov M, Gameiro SF, Maleki Vareki S, Mymryk JS. HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct. JCM 2022;11:4825. [DOI: 10.3390/jcm11164825] [Reference Citation Analysis]
5 Salnikov M, Gameiro SF, Zeng PYF, Barrett JW, Nichols AC, Mymryk JS. The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis. mSphere 2022;:e0031722. [PMID: 35950764 DOI: 10.1128/msphere.00317-22] [Reference Citation Analysis]
6 Poniewierza P, Panek G. Cervical Cancer Prophylaxis—State-of-the-Art and Perspectives. Healthcare 2022;10:1325. [DOI: 10.3390/healthcare10071325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]